Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.

Irwin DJ, Trojanowski JQ, Grossman M.

Front Aging Neurosci. 2013 Feb 21;5:6. doi: 10.3389/fnagi.2013.00006. eCollection 2013.

2.

Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.

Baldeiras I, Santana I, Leitão MJ, Ribeiro MH, Pascoal R, Duro D, Lemos R, Santiago B, Almeida MR, Oliveira CR.

J Neurol Sci. 2015 Nov 15;358(1-2):308-16. doi: 10.1016/j.jns.2015.09.022. Epub 2015 Sep 10.

PMID:
26388316
3.

CSF biomarkers in frontotemporal lobar degeneration with known pathology.

Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M, Moore P, de Koning I, Clark CM, Rosso S, Trojanowski J, Lee VM, Grossman M.

Neurology. 2008 May 6;70(19 Pt 2):1827-35. doi: 10.1212/01.wnl.0000311445.21321.fc.

4.

Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH.

Brain. 2014 Apr;137(Pt 4):1176-92. doi: 10.1093/brain/awu024. Epub 2014 Feb 25.

5.

Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms.

Irwin DJ, McMillan CT, Toledo JB, Arnold SE, Shaw LM, Wang LS, Van Deerlin V, Lee VM, Trojanowski JQ, Grossman M.

Arch Neurol. 2012 Aug;69(8):1018-25. doi: 10.1001/archneurol.2012.26.

6.

Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia.

Borroni B, Benussi A, Archetti S, Galimberti D, Parnetti L, Nacmias B, Sorbi S, Scarpini E, Padovani A.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):86-91. doi: 10.3109/21678421.2014.971812. Epub 2014 Oct 29.

PMID:
25352065
7.

Can MRI screen for CSF biomarkers in neurodegenerative disease?

McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M.

Neurology. 2013 Jan 8;80(2):132-8. doi: 10.1212/WNL.0b013e31827b9147. Epub 2012 Dec 26.

8.

Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration.

Galimberti D, Scarpini E.

Int J Clin Exp Med. 2010 May 15;3(2):129-43.

9.

Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.

Hu WT, Watts K, Grossman M, Glass J, Lah JJ, Hales C, Shelnutt M, Van Deerlin V, Trojanowski JQ, Levey AI.

Neurology. 2013 Nov 26;81(22):1945-52. doi: 10.1212/01.wnl.0000436625.63650.27. Epub 2013 Oct 30.

10.

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.

PMID:
21721431
11.

White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.

McMillan CT, Irwin DJ, Avants BB, Powers J, Cook PA, Toledo JB, McCarty Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ, Grossman M.

J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):949-55. doi: 10.1136/jnnp-2012-304418. Epub 2013 Mar 9.

12.

Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.

Ishiki A, Kamada M, Kawamura Y, Terao C, Shimoda F, Tomita N, Arai H, Furukawa K.

J Neurochem. 2016 Jan;136(2):258-61. doi: 10.1111/jnc.13399. Epub 2015 Nov 11.

PMID:
26485083
13.

Novel CSF biomarkers for frontotemporal lobar degenerations.

Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Neurology. 2010 Dec 7;75(23):2079-86. doi: 10.1212/WNL.0b013e318200d78d. Epub 2010 Nov 3.

14.

Cerebrospinal fluid biomarkers in Progranulin mutations carriers.

Carecchio M, Fenoglio C, Cortini F, Comi C, Benussi L, Ghidoni R, Borroni B, De Riz M, Serpente M, Cantoni C, Franceschi M, Albertini V, Monaco F, Rainero I, Binetti G, Padovani A, Bresolin N, Scarpini E, Galimberti D.

J Alzheimers Dis. 2011;27(4):781-90. doi: 10.3233/JAD-2011-111046.

PMID:
21891865
15.

Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.

Oeckl P, Steinacker P, Feneberg E, Otto M.

Biochim Biophys Acta. 2015 Jul;1854(7):757-68. doi: 10.1016/j.bbapap.2014.12.010. Epub 2014 Dec 17. Review.

PMID:
25526887
16.

Additional value of CSF amyloid-beta 40 levels in the differentiation between FTLD and control subjects.

Verwey NA, Kester MI, van der Flier WM, Veerhuis R, Berkhof H, Twaalfhoven H, Blankenstein MA, Scheltens And P, Pijnenburg YA.

J Alzheimers Dis. 2010;20(2):445-52. doi: 10.3233/JAD-2010-1392.

PMID:
20164558
17.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6. Review.

PMID:
22503777
18.

Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration.

Kapaki E, Paraskevas GP, Papageorgiou SG, Bonakis A, Kalfakis N, Zalonis I, Vassilopoulos D.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):47-53. doi: 10.1097/WAD.0b013e3181610fea.

PMID:
18317246
19.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Epub 2010 Jul 22. Review.

20.

Clinical accuracy of the distinction between Alzheimer's disease and frontotemporal lobar degeneration.

Sutovsky S, Blaho A, Kollar B, Siarnik P, Csefalvay Z, Dragasek J, Turcani P.

Bratisl Lek Listy. 2014;115(3):161-7.

PMID:
24579686
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk